CLADRIBINE INJECTION
Google image searchProduct monograph
Active ingredient
cladribine, 1 MG/ML
DIN: 02319918
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 22-AUG-2016
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BB — Purine analogues (ATC, ATC/DDD)
- L01BB04 — CLADRIBINE (ATC/DDD)
Reference brand drug: Leustatin
Pharmaceutical standard: USP
